🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Walgreens shares drop as S&P 500 edges higher

EditorHari Govind
Published 17/11/2023, 00:30
© Pavlo Gonchar / SOPA Images/Sipa via Reuters Connect
US500
-
DJI
-
MCK
-
CVS
-
WBA
-

NEW YORK - Shares of Walgreens Boots Alliance (NASDAQ:WBA) Inc. took a downturn on Thursday, ending a two-day streak of gains amid a mixed trading session. The pharmacy chain's stock declined by 3.71% to close at $20.75, significantly trailing its year-high of $42.29 set last December.

The broader market saw a modest uptick, with the S&P 500 Index inching up by 0.12% to finish at 4,508.24. Meanwhile, the Dow Jones Industrial Average slightly retreated, closing down 0.13% at 34,945.47.

Walgreens' performance stood out on a day where its peers and competitors, including Amazon.com Inc (NASDAQ:AMZN)., CVS Health Corp (NYSE:CVS)., and McKesson Corp (NYSE:MCK)., did not face similar declines. The trading volume for Walgreens was notably lower than average, with only 10.7 million shares changing hands compared to its usual volume, falling short by approximately 2 million shares.

Investors are reflecting on Walgreens' current market position as it fell $21.54 below its peak from the previous year, signaling a period of underperformance relative to the sector. This comes during a time when the retail pharmacy industry faces challenges and increased competition from both brick-and-mortar and online entities.

InvestingPro Insights

Based on real-time data from InvestingPro, Walgreens Boots Alliance Inc. (WBA) has a market capitalization of 17.93 billion USD. The company's Price/Earnings ratio is currently at -5.81, indicating that the market has been pricing the stock below its earnings potential. However, the adjusted P/E ratio as of Q4 2023 is 10.15, suggesting an anticipated improvement in earnings. Moreover, the company's revenue growth for Q4 2023 is projected at 4.81%.

Two key InvestingPro Tips to consider are: Walgreens has a history of consistent dividend payments, having raised its dividend for 48 consecutive years. This is a positive sign for investors seeking steady income. Moreover, despite the recent downturn, Walgreens remains a prominent player in the Consumer Staples Distribution & Retail industry, which could indicate potential for recovery.

For more in-depth analysis and additional tips, consider exploring InvestingPro's comprehensive suite of investing tools. There are 13 additional tips available for Walgreens on the platform, providing a more holistic view of the company's performance and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.